L’avis urgent intitulé « Utilisation du vaccin IXCHIQ dans le contexte épidémique de chikungunya dans les territoires de La Réunion et de Mayotte », ci-joint, est adopté.
See also
Vaccine recommendation
05/03/2025
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
zHJBsbYU9QGDgLaK
